NO20025898D0 - Fremgangsmåte for å öke overlevelsesraten til akvatiske dyr eksponert for en akvatisk virus og sammensetninger til bruk for slikefremgangsmåter - Google Patents

Fremgangsmåte for å öke overlevelsesraten til akvatiske dyr eksponert for en akvatisk virus og sammensetninger til bruk for slikefremgangsmåter

Info

Publication number
NO20025898D0
NO20025898D0 NO20025898A NO20025898A NO20025898D0 NO 20025898 D0 NO20025898 D0 NO 20025898D0 NO 20025898 A NO20025898 A NO 20025898A NO 20025898 A NO20025898 A NO 20025898A NO 20025898 D0 NO20025898 D0 NO 20025898D0
Authority
NO
Norway
Prior art keywords
aquatic
infection
bimavirus
increasing
animals
Prior art date
Application number
NO20025898A
Other languages
English (en)
Other versions
NO20025898L (no
Inventor
Ana Maria Sandino Garcia
Geraldine Mlynarz Zylberberg
Original Assignee
Geraldine Mlynarz Zylberberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42140308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20025898(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geraldine Mlynarz Zylberberg filed Critical Geraldine Mlynarz Zylberberg
Publication of NO20025898D0 publication Critical patent/NO20025898D0/no
Publication of NO20025898L publication Critical patent/NO20025898L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
NO20025898A 2001-12-07 2002-12-09 Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus NO20025898L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33668401P 2001-12-07 2001-12-07

Publications (2)

Publication Number Publication Date
NO20025898D0 true NO20025898D0 (no) 2002-12-09
NO20025898L NO20025898L (no) 2003-06-10

Family

ID=42140308

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20025898A NO20025898L (no) 2001-12-07 2002-12-09 Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus
NO20110661A NO335129B1 (no) 2001-12-07 2011-05-03 Anvendelse av neomycin for fremstilling av et medikament for behandling eller forebygging av infeksjon med infeksiøst pankreatisk nekrose virus (IPNV) hos akvatiske dyr

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20110661A NO335129B1 (no) 2001-12-07 2011-05-03 Anvendelse av neomycin for fremstilling av et medikament for behandling eller forebygging av infeksjon med infeksiøst pankreatisk nekrose virus (IPNV) hos akvatiske dyr

Country Status (9)

Country Link
US (2) US7652050B2 (no)
EP (2) EP1317923B1 (no)
AT (2) ATE522212T1 (no)
CA (1) CA2428703A1 (no)
CL (1) CL2008003293A1 (no)
DE (1) DE60236136D1 (no)
DK (2) DK2193792T3 (no)
ES (2) ES2345244T3 (no)
NO (2) NO20025898L (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5101508B2 (ja) * 2005-08-29 2012-12-19 ノバルティス アーゲー 魚寄生虫制御のためのオキサゾール誘導体の使用
NO20055541L (no) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues
WO2011154771A1 (es) * 2010-06-08 2011-12-15 Laboratorio De Diagnostico Gam, S.A. Uso de 1-beta-d-ribofuranosil-1h-1,2,4-triazol-3-carboxamida para el tratamiento de la anemia infecciosa del salmón (isa) en salmónidos
WO2013059168A2 (en) * 2011-10-21 2013-04-25 Research Development Foundation Espirito santo virus and methods for detecting and preventing infection with the same
KR101540696B1 (ko) 2014-12-12 2015-08-03 대한민국 바이러스 내성 넙치 육종 방법
WO2023121362A1 (ko) * 2021-12-22 2023-06-29 씨제이제일제당 (주) 핵산 유래 뉴클레오사이드 아날로그 및 이들의 약학적으로 허용가능한 염을 포함하는 항바이러스용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878047A (en) 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US4225720A (en) 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
US4232164A (en) 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
USRE31578E (en) 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4256898A (en) 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
JPS5793968A (en) * 1980-11-11 1982-06-11 Sankyo Co Ltd Carbamic acid ester and insecticide containing the same
US4843087A (en) * 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
US5087639A (en) * 1988-11-02 1992-02-11 The Upjohn Company Preventing CNS toxicity of acivicin when used with four large neutral amino acids
RU2060010C1 (ru) 1989-12-27 1996-05-20 Фудзисава Фармасьютикал Ко., Лтд. Корм для рыб
US5349068A (en) 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US20020058911A1 (en) * 1999-05-07 2002-05-16 Paul Gilson Support frame for an embolic protection device
US6540722B1 (en) * 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6689151B2 (en) * 2001-01-25 2004-02-10 Scimed Life Systems, Inc. Variable wall thickness for delivery sheath housing
EP1455686A2 (en) * 2001-12-21 2004-09-15 Salviac Limited A support frame for an embolic protection device
US8182508B2 (en) * 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US20070239198A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Filter and wire with distal isolation

Also Published As

Publication number Publication date
DK2193792T3 (da) 2012-01-02
NO20110661L (no) 2003-06-10
DK1317923T3 (da) 2010-08-09
US7652050B2 (en) 2010-01-26
US8044031B2 (en) 2011-10-25
EP2193792A1 (en) 2010-06-09
CA2428703A1 (en) 2004-11-14
EP1317923A2 (en) 2003-06-11
ATE465730T1 (de) 2010-05-15
DE60236136D1 (de) 2010-06-10
ATE522212T1 (de) 2011-09-15
US20030191169A1 (en) 2003-10-09
EP1317923A3 (en) 2003-09-10
EP2193792B1 (en) 2011-08-31
ES2345244T3 (es) 2010-09-20
NO335129B1 (no) 2014-09-22
US20100204290A1 (en) 2010-08-12
CL2008003293A1 (es) 2009-03-20
EP1317923B1 (en) 2010-04-28
NO20025898L (no) 2003-06-10
ES2372915T3 (es) 2012-01-27

Similar Documents

Publication Publication Date Title
DE69935721D1 (de) Kälte-adaptierte pferde influenza-viren
DE602004014791D1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
EA200500610A1 (ru) Композиция для лечения инфекции, вызываемой вирусами семейств flaviviridae
CL2008003293A1 (es) Uso de neomicina para preparar un medicamento para tratar y prevenir una infección causada por un virus birnaviridae en un animal acuatico (div. sol. n°2800-02)
RU2016129272A (ru) Применение изоксазолиновых соединений на домашней птице
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
WO2001060849A3 (en) Cold-adapted equine influenza viruses
JP2018172383A5 (ja) 魚介類のベコ病の経口投与用治療剤組成物及びそれを用いた魚介類のベコ病の治療方法
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
DE59109225D1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
BR0311970A (pt) Novos compostos, seu uso e preparação
US7140323B2 (en) Reducing the level of bacteria and viruses in aquaculture
BRPI0417300A (pt) métodos para a preparação de compostos de tiazolpirimidina
RU2365594C2 (ru) Применение циклических пептидов анабенопептинового типа для лечения состояния, при котором полезно ингибирование карбоксипептидазы u, новые анабенопептиновые производные и их промежуточные соединения
DK0865278T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af slimhinde-sygdomme, som er vanskeligt at behandle
NO20052774L (no) Topiske preparater og bruk av disse for behandling av vannlevende dyr utsatt for desinfeksjon og vaksinasjon.
DE60310975D1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
BR0314526A (pt) Composições farmacêuticas para o tratamento do mal de parkinson
EA200600659A1 (ru) Фунгицидные смеси для борьбы с патогенами риса
RU2002133057A (ru) Способ оральной иммунизации птицы против ньюкаслской болезни
ECSP003482A (es) Agentes inmunopotenciadores
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

FC2A Withdrawal, rejection or dismissal of laid open patent application